Celldex Therapeutics to Participate in the Cantor Fitzgerald 2nd Annual Healthcare Conference
July 07 2016 - 4:01PM
Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that Tibor
Keler, Ph.D., Executive Vice President and Chief Scientific
Officer, will participate in a fireside chat at the Cantor
Fitzgerald 2nd Annual Healthcare Conference on July 12, 2016 at
9:00 a.m. EDT in New York.
The live webcast will be available on the “Events &
Presentations” page of the “Investors & Media” section of the
Celldex website. A replay will be available for seven days
following the event.
About Celldex Therapeutics, Inc. Celldex is
developing targeted therapeutics to address devastating diseases
for which available treatments are inadequate. Our pipeline is
built from a proprietary portfolio of antibodies and
immunomodulators used alone and in strategic combinations to create
novel, disease-specific therapies that induce, enhance or suppress
the body's immune response. Visit www.celldex.com.
Company Contact:
Sarah Cavanaugh
Vice President of Investor Relations & Corp Communications
Celldex Therapeutics, Inc.
(781) 433-3161
scavanaugh@celldex.com
Charles Liles
Manager of Investor Relations & Corp Communications
Celldex Therapeutics, Inc.
(781) 433-3107
cliles@celldex.com
Celldex Therapeutics (NASDAQ:CLDX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Celldex Therapeutics (NASDAQ:CLDX)
Historical Stock Chart
From Apr 2023 to Apr 2024